In continuing to follow the legal challenge by Intermune against the European Medicines Agency I began to wonder if DG SANCO and the European Commission as a whole were fully supportive of the EMA’s initiative on transparency. Perhaps there were expressions of support but I had not seen any. I had also heard, at second or third hand, reports of a senior official in DG SANCO criticising the EMA initiative on the supposed grounds that it would damage the industry.
I am glad to say that I have been able to clarify this point because I recently had the opportunity to ask Commissioner Tonio Borg himself about it. My question was a short one and his answer even shorter.
“Does the Commission support the new transparency policy of the European Medicines Agency?” I asked.
“Yes, we do”. he replied.
No room for ambiguity there. I am grateful to the Commissioner for his positive and clear answer. ENDAuthor : Jim Murray